hand-foot syndrome
Conditions
Interventions
control group:Matrix control group
Experimental:Shencaoshouzurunfu Cream
Sponsors
Guanganmen Hospital, China Academy of Chinese Medical Science
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Confirmed by pathology or cytology for malignant tumor; 2. Level 1 or above HFS after chemotherapy; 3. Karnofsky scores>60; 4. No serious heart, liver, kidney and other important viscera dysfunction; 5. expected lifetime >3 months; 6. Ages 18 to 80 years; 7. Good compliance; 8. Voluntary participation and sign a consent form.
Exclusion criteria
Exclusion criteria: 1. Do not meet above are included in the standard; 2. The original diseases of the nervous system; 3. Diabetes with nerve system disease; 4. Have serious heart, liver, kidney and other important viscera dysfunction; 5. Are receiving may cause other than the neurotoxicity of chemotherapy drug treatment; 6. Bad compliance; 7. Not subject to control infection and metabolic disease; 8. regnant women or mentally ill.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the decrease of NCI grades of hand-foot syndrom; | — |
Secondary
| Measure | Time frame |
|---|---|
| quality of life;TCM syndrome scores;Tumor common symptom questionnaire; | — |
Countries
China
Contacts
Public ContactHongsheng Lin
Guanganmen Hospital, China Academy of Chinese Medical Science
Outcome results
None listed